[go: up one dir, main page]

CA2180155A1 - Naphtylamides comme agents actifs sur le systeme nerveux central - Google Patents

Naphtylamides comme agents actifs sur le systeme nerveux central

Info

Publication number
CA2180155A1
CA2180155A1 CA002180155A CA2180155A CA2180155A1 CA 2180155 A1 CA2180155 A1 CA 2180155A1 CA 002180155 A CA002180155 A CA 002180155A CA 2180155 A CA2180155 A CA 2180155A CA 2180155 A1 CA2180155 A1 CA 2180155A1
Authority
CA
Canada
Prior art keywords
naphthylamides
nervous system
central nervous
agents
system agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002180155A
Other languages
English (en)
Other versions
CA2180155C (fr
Inventor
Shelly Ann Glase
Suzanne Ross Kesten
Lawrence David Wise
Jonathan Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/217,395 external-priority patent/US5395835A/en
Application filed by Individual filed Critical Individual
Publication of CA2180155A1 publication Critical patent/CA2180155A1/fr
Application granted granted Critical
Publication of CA2180155C publication Critical patent/CA2180155C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002180155A 1994-03-24 1995-02-16 Naphtylamides comme agents actifs sur le systeme nerveux central Expired - Fee Related CA2180155C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US217,395 1988-07-11
US08/217,395 US5395835A (en) 1994-03-24 1994-03-24 Naphthalamides as central nervous system agents
PCT/US1995/001974 WO1995025727A1 (fr) 1994-03-24 1995-02-16 Naphtylamides comme agents actifs sur le systeme nerveux central

Publications (2)

Publication Number Publication Date
CA2180155A1 true CA2180155A1 (fr) 1995-09-28
CA2180155C CA2180155C (fr) 2006-02-14

Family

ID=35892270

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002180155A Expired - Fee Related CA2180155C (fr) 1994-03-24 1995-02-16 Naphtylamides comme agents actifs sur le systeme nerveux central

Country Status (1)

Country Link
CA (1) CA2180155C (fr)

Also Published As

Publication number Publication date
CA2180155C (fr) 2006-02-14

Similar Documents

Publication Publication Date Title
AU1877495A (en) Naphthylamides as central nervous system agents
SI0725779T1 (fr)
HUP9701096A3 (en) Use of benzenesulfonamides for the preparation of pharmaceutical compositions treating disorders of the central nervous system, novel derivatives, process for their preparation and pharmaceutical compositions containing them
AU6770290A (en) Substituted cyclohexanols as central nervous system agents
AU4520697A (en) Use of substituted benzazoles as UV absorbers, new benzazoles and processes for their preparation
DE69429524D1 (de) Aminocyclohexylester und ihre anwendung
NZ313606A (en) Benzo[g]quinoline derivatives and pharmaceutical compositions thereof for treating depression, anxiety and bipolar disorders
CA2094702A1 (fr) Derives de substitution de tetrahydropyridines et d'hydroxypiperidines, agents therapeutiques pour le systeme nerveux central
AU1945795A (en) Thieno{ 2,3-b}indoles, their preparation and use
WO1992007832A3 (fr) Piperazines substituees utilisees comme agents de traitement du systeme nerveux central
CA2122911A1 (fr) Cycloalcenes et cycloalcanes substitues en 1,3, utilises comme agents du systeme nerveux central
CA2284551A1 (fr) Nouvelles combinaisons therapeutiques de la mirtazapine et d'agents antipsychotiques pour le traitement ou la prophylaxie de psychoses
AU4674797A (en) Phenylalaninol derivatives for the treatment of central nervous system disorders
CA2347863A1 (fr) Traitement des affections de la retine
HUP0103832A3 (en) Triazolopyridines for the treatment of thrombosis disorders, pharmaceutical compositions containing the same and process for preparation thereof
AU6770190A (en) Substituted cyclohexenes as central nervous system agents
CA2260863A1 (fr) Traitement de troubles d'ordre psychotique
CA2180155A1 (fr) Naphtylamides comme agents actifs sur le systeme nerveux central
CA2130563A1 (fr) Derive de 2,6-methano-2h-qinolizine, antagoniste du recepteur 5-ht3
MXPA98005355A (es) Derivados de 5-[(heteroaril) alquil]-3 -oxo-pirido [1, 2-a]bencimidazol -4-carboxamida utiles en el tratamiento de trastornos del sistema nervioso central.
AU4448497A (en) Novel 6 or 7 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
AU3978095A (en) Heterocyclic compounds and their preparation and use
WO1999019324A3 (fr) Derives de piperidine substitues

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed